Related references
Note: Only part of the references are listed.Therapeutic monitoring of plasma clozapine and N-desmethylclozapine (norclozapine): practical considerations
Robert J. Flanagan et al.
BJPSYCH ADVANCES (2023)
Adverse Drug Reactions in Relation to Clozapine Plasma Levels: A Systematic Review
Maria Skokou et al.
PHARMACEUTICALS (2022)
Caffeine-clozapine interaction associated with severe toxicity and multiorgan system failure: a case report
Alex Yartsev et al.
BMC PSYCHIATRY (2021)
Clinical and genetic influencing factors on clozapine pharmacokinetics in Tunisian schizophrenic patients
Helmi Ammar et al.
PHARMACOGENOMICS JOURNAL (2021)
The CYP2C19*2 and CYP2C19*17 Polymorphisms Influence Responses to Clozapine for the Treatment of Schizophrenia
Christielly Rodrigues-Silva et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2020)
Impact of CYP1A2 genetic polymorphisms on pharmacokinetics of antipsychotic drugs: a systematic review and meta-analysis
M. Na Takuathung et al.
ACTA PSYCHIATRICA SCANDINAVICA (2019)
Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis
Maximilian Huhn et al.
LANCET (2019)
A Novel PCR-RFLP Method for Detection of POR*28 Polymorphism and its Genotype/Allele Frequencies in a Turkish Population
Fezile Ozdemir et al.
CURRENT DRUG METABOLISM (2019)
PharmGKB summary: clozapine pathway, pharmacokinetics
Caroline F. Thorn et al.
PHARMACOGENETICS AND GENOMICS (2018)
Clozapine Pharmacogenetic Studies in Schizophrenia: Efficacy and Agranulocytosis
Shusuke Numata et al.
FRONTIERS IN PHARMACOLOGY (2018)
Relationship between clozapine dose, serum concentration, and clinical outcome in children and adolescents in clinical practice
Christopher Wohkittel et al.
JOURNAL OF NEURAL TRANSMISSION (2016)
Cigarette smoking has a differential effect on the plasma level of clozapine in Taiwanese schizophrenic patients associated with the CYP1A2 gene-163A/C single nucleotide polymorphism
Hui-Ching Huang et al.
PSYCHIATRIC GENETICS (2016)
Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics
John Lally et al.
PHARMACOGENOMICS & PERSONALIZED MEDICINE (2016)
Correlation of Cytochrome P450 Oxidoreductase Expression with the Expression of 10 Isoforms of Cytochrome P450 in Human Liver
Hai-Feng Zhang et al.
DRUG METABOLISM AND DISPOSITION (2016)
Optimising plasma levels of clozapine during metabolic interactions: a review and case report with adjunct rifampicin treatment
Siobhan Gee et al.
BMC PSYCHIATRY (2015)
The influence of CYP3A, PPARA, and POR genetic variants on the pharmacokinetics of tacrolimus and cyclosporine in renal transplant recipients
Ingrid Lunde et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Meta-analysis: the effects of smoking on the disposition of two commonly used antipsychotic agents, olanzapine and clozapine
Yoshiyuki Tsuda et al.
BMJ OPEN (2014)
Impact of POR*28 on the clinical pharmacokinetics of CYP3A phenotyping probes midazolam and erythromycin
Laure Elens et al.
PHARMACOGENETICS AND GENOMICS (2013)
Diagnostic and statistical manual of mental disorders 5: A quick glance
Vihang N. Vahia
INDIAN JOURNAL OF PSYCHIATRY (2013)
Characterization of Human Cytochrome P450s Involved in the Bioactivation of Clozapine
Sanja Dragovic et al.
DRUG METABOLISM AND DISPOSITION (2013)
PharmGKB summary: very important pharmacogene information for CYP1A2
Caroline F. Thorn et al.
PHARMACOGENETICS AND GENOMICS (2012)
The P450 oxidoreductase*28 SNP is associated with low initial tacrolimus exposure and increased dose requirements in CYP3A5-expressing renal recipients
Hylke de Jonge et al.
PHARMACOGENOMICS (2011)
AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011
C. Hiemke et al.
PHARMACOPSYCHIATRY (2011)
Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2
Shu-Feng Zhou et al.
DRUG METABOLISM REVIEWS (2010)
Effects of genetic variants of human P450 oxidoreductase on catalysis by CYP2D6 in vitro
Duanpen Sandee et al.
PHARMACOGENETICS AND GENOMICS (2010)
Substrate-specific modulation of CYP3A4 activity by genetic variants of cytochrome P450 oxidoreductase
Vishal Agrawal et al.
PHARMACOGENETICS AND GENOMICS (2010)
Caffeine Metabolic Ratios for the In Vivo Evaluation of CYP1A2, N-acetyltransferase 2, Xanthine Oxidase and CYP2A6 Enzymatic Activities
Nancy M. Kh. Hakooz
CURRENT DRUG METABOLISM (2009)
ABCB1 polymorphisms are associated with clozapine plasma levels in psychotic patients
Giorgio Consoli et al.
PHARMACOGENOMICS (2009)
The relative contribution of human cytochrome P450 isoforms to the four caffeine oxidation pathways:: An in vitro comparative study with cDNA-expressed P450s including CYP2C isoforms
Marta Kot et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Pharmacogenetics of P450 oxidoreductase: effect of sequence variants on activities of CYP1A2 and CYP2C19
Vishal Agrawal et al.
PHARMACOGENETICS AND GENOMICS (2008)
Gender, age, smoking behaviour and plasma clozapine concentrations in 193 Chinese inpatients with schizophrenia
Yi-lang Tang et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2007)
The CYP1A2 genotype modifies the association between coffee consumption and breast cancer risk among BRCA1 mutation carriers
Joanne Kotsopoulos et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Determination of clozapine and its metabolite, norclozapine in various biological matrices using high-performance liquid chromatography
Micheal Rosland et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2007)
The effect of variable cigarette consumption on the interaction with clozapine and olanzapine
Tore Haslemo et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2006)
The effect of smoking and cytochrome P450CYP1A2 genetic polymorphism on clozapine clearance and dose requirement
J van der Weide et al.
PHARMACOGENETICS (2003)
Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: A review and meta-analysis of randomized trials
M Chakos et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
Effect of caffeine on clozapine pharmacokinetics in healthy volunteers
S Hagg et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2000)
Share Paper
